abstract |
The present invention relates to oncolytic adenoviral vectors and chemotherapeutic agents. More specifically, the invention relates to oncolytic adenoviral vectors and chemotherapeutic agents for cancer treatment. The combination therapy as described herein has an excellent safety profile and potent therapeutic activity. |